Infection is the second leading cause of death and the number one cause for hospitalization in patients on dialysis. 1 The National Healthcare Safety Network (NHSN) reported 29,516 bloodstream infections in outpatient hemodialysis centers in 2014, 2 and 77% were considered vascular access-related. Nearly 70% of access-related bloodstream infections occurred in patients with a central venous catheter (CVC). Thus, use of CVC remains a leading cause of mortality and hospitalization for patients on hemodialysis.
In this issue of the Journal of the American Society of Nephrology, Brunelli et al. 3 report the results of a 13-month prospective, cluster-randomized study in patients on hemodialysis with CVC vascular access. They compared use of a catheter closure device, which uses rod and threads containing dry chlorhexidine and thus applies disinfectant between dialysis treatments, with a similar disinfecting cap that applies disinfectant only on the outside of the catheter connector. They found that the chlorhexidine-containing device inside the catheter lumen resulted in significantly fewer positive blood cultures and catheter-related bloodstream infections for both Gram-positive and Gram-negative infections, and resulted in fewer antibiotic starts. Although other comparisons of antibacterial lock solutions 4 have suggested efficacy in reducing infections, this is the largest prospective, randomized controlled study to show reduced infections to date.
Reducing CVC use and increasing use of arteriovenous fistulas and grafts may be the best way to reduce vascular access-related bloodstream infections. Nevertheless, CVCs will remain for a subset of patients on hemodialysis, whether used as a bridge to a more permanent vascular access or used for longer periods in patients with small blood vessels, multiple previous vascular procedures, frail and/or elderly patients, or others who simply choose to have no further vascular access procedures. For such patients, devices such as the one studied here may contribute to fewer hospitalizations and reduced preventable infections. The Centers for Disease Control and Prevention (CDC) has published a list of core interventions for blood stream infection prevention, 5 and provides checklists and audit tools to monitor these interventions. The core interventions include:
c Surveillance and feedback using NHSN. c Meticulous use of hand hygiene, and observations of its use and consistency. c Training staff and patients about infection prevention, and assessing competency. c Using best practice in catheter/vascular access care, and observing use and consistency. c CVC reduction. c Chlorhexidine skin preparation, including adequate area of disinfection and drying time. c Catheter hub disinfection ("scrub the hub"). c Antimicrobial ointment to the catheter exit site during dressing changes.
Perhaps the largest challenge for dialysis staff and patients is how to use devices like the one studied here, and engage all of the CDC-recommended practices in the setting of real-world busy dialysis facilities. Dialysis staff work hard to give patients their required treatments and individual care as well as keep them safe. Whose responsibility is it to eliminate preventable blood stream infections? In 2016, the CDC awarded a grant to the American Society of Nephrology to develop a program to engage nephrologists and dialysis medical directors to target zero infections in hemodialysis facilities. 6 Nephrologists Transforming Dialysis Safety (NTDS) has worked to share knowledge, bring experts in healthcare-associated infection at the state and federal level together with nephrologists, teach the next generation of nephrologists, and learn from previous experiences such as the Ebola outbreak, to prepare dialysis facilities to respond to the next highly infectious disease that may threaten patients on dialysis. In addition to catheter/vascular access-related infections, NTDS has considered other bloodborne diseases such as hepatitis C, and has examined the importance and effectiveness of antibiotic stewardship programs to reduce unnecessary or inappropriate antibiotic treatment. These programs can reduce the incidence of multiple drug-resistant organisms that are more common in patients on hemodialysis than in the general population. 7 To accomplish this large task, NTDS believes that nephrologists must assume a major role in the responsibility to target
